Strategic Wealth Partners, Ltd. Baxter International Inc Transaction History

Strategic Wealth Partners, Ltd.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 22, 2022	SELL	$63.83 - $80.0 $984,577 - $1.23 Million	-15,425 Closed	0 $0
Q1 2022 May 19, 2022	BUY	$76.85 - $89.45 $180,597 - $210,207	2,350 Added 17.97%	15,425 $1.2 Million
Q4 2021 Feb 11, 2022	BUY	$74.57 - $87.19 $132,436 - $154,849	1,776 Added 15.72%	13,075 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$73.77 - $83.61 $833,527 - $944,709	11,299 New	11,299 $909,000
Q4 2019 Jan 30, 2020	SELL	$76.7 - $88.45 $243,445 - $280,740	-3,174 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$81.4 - $89.78 $600,325 - $662,127	-7,375 Reduced 69.91%	3,174 $119 Million
Q2 2019 Aug 06, 2019	BUY	$73.44 - $82.41 $58,091 - $65,186	791 Added 8.11%	10,549 $865,000
Q1 2019 May 14, 2019	BUY	$64.48 - $81.31 $538,536 - $679,101	8,352 Added 594.03%	9,758 $797,000
Q4 2018 Jan 24, 2019	BUY	$61.45 - $77.8 $85,169 - $107,830	1,386 Added 6930.0%	1,406 $92,000
Q1 2018 Jul 13, 2018	BUY	$62.56 - $72.26 $1,251 - $1,445	20 New	20 $1,000

989

448M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.1B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Strategic Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Strategic Wealth Partners, Ltd. with notifications on news.